Reposted
☢️💊💉Trimodality therapy offers hope for recurrent T1 bladder cancer after BCG failure!
✅ 3-year freedom from cystectomy: 88%
✅ 3-year OS: 69%
🔷monitoring is key.
#BladderCancer #Oncology
@oncoalert.bsky.social @oncbrothers.bsky.social
@achoud72.bsky.social
✅ 3-year freedom from cystectomy: 88%
✅ 3-year OS: 69%
🔷monitoring is key.
#BladderCancer #Oncology
@oncoalert.bsky.social @oncbrothers.bsky.social
@achoud72.bsky.social
November 27, 2024 at 12:49 AM
☢️💊💉Trimodality therapy offers hope for recurrent T1 bladder cancer after BCG failure!
✅ 3-year freedom from cystectomy: 88%
✅ 3-year OS: 69%
🔷monitoring is key.
#BladderCancer #Oncology
@oncoalert.bsky.social @oncbrothers.bsky.social
@achoud72.bsky.social
✅ 3-year freedom from cystectomy: 88%
✅ 3-year OS: 69%
🔷monitoring is key.
#BladderCancer #Oncology
@oncoalert.bsky.social @oncbrothers.bsky.social
@achoud72.bsky.social
Trimodal therapy (TURBT + radiation + chemo) for muscle-invasive bladder cancer offers a great bladder-sparing alternative to surgery, improving survival and local control. #BladderCancer www.sciencedirect.com/science/arti...
Concomitant Chemotherapy in Trimodal Treatment of Patients with Muscle Invasive Bladder Cancer: A Systematic Review of Prospective Trials
For selected patients with muscle-invasive bladder cancer (MIBC), trimodal therapy (TMT) incorporating transurethral resection of the tumor and chemor…
www.sciencedirect.com
November 24, 2024 at 7:34 AM
Trimodal therapy (TURBT + radiation + chemo) for muscle-invasive bladder cancer offers a great bladder-sparing alternative to surgery, improving survival and local control. #BladderCancer www.sciencedirect.com/science/arti...